Academic Journal
Pharmacoinformational, gerontoinformational and chemoreactomic analysis of the molecule of citrulline malate, carnitine, sulbutiamine and meldonium to identify the molecular mechanisms of antiasthenic action ; Фармакоинформационный, геронтоинформационный и хемореактомный анализ молекулы цитруллина малата, карнитина, сульбутиамина и мельдония для выявления молекулярных механизмов антиастенического действия
| العنوان: | Pharmacoinformational, gerontoinformational and chemoreactomic analysis of the molecule of citrulline malate, carnitine, sulbutiamine and meldonium to identify the molecular mechanisms of antiasthenic action ; Фармакоинформационный, геронтоинформационный и хемореактомный анализ молекулы цитруллина малата, карнитина, сульбутиамина и мельдония для выявления молекулярных механизмов антиастенического действия |
|---|---|
| المؤلفون: | I. Yu. Torshin, O. A. Gromova, И. Ю. Торшин, О. А. Громова |
| المساهمون: | The work was carried out within the using the infrastructure of the Federal Research Center “Computer Science and Control” of the Russian Academy of Sciences., работа выполнена с использованием инфраструктуры Центра коллективного пользования «Высокопроизводительные вычисления и большие данные» ФИЦ «Информатика и управление» РАН. |
| المصدر: | Meditsinskiy sovet = Medical Council; № 3 (2024); 70-79 ; Медицинский Совет; № 3 (2024); 70-79 ; 2658-5790 ; 2079-701X |
| بيانات النشر: | REMEDIUM GROUP Ltd. |
| سنة النشر: | 2024 |
| المجموعة: | Medical Council (E-Journal) / Медицинский Совет |
| مصطلحات موضوعية: | фармакоинформатика, pharmacotherapy, micronutrient homeostasis, citrulline malate, pharmacoinformatics, фармакотерапия, гомеостаз микронутриентов, цитруллина малат |
| الوصف: | The pathophysiology of asthenia is very complex and is associated with chronic kidney disease, heart failure, chronic obstructive pulmonary disease, sarcopenia, bacterial and viral pathogens, micronutrient nutritional imbalances, hypothyroidism, etc. Asthenia can occur with excessive (for a given patient) physical, mental or mental stress and adaptation disorders or be iatrogenic in nature (in particular, due to taking medications that contribute to increased loss of vitamins and microelements), incl. due to unwanted drug interactions. The complex nature of the pathophysiology of asthenia necessitates the use of a differentiated approach aimed at eliminating the main cause of asthenia in a given patient. If asthenia is associated primarily with disorders of energy metabolism, then the pathophysiological treatment is the use of nutrients that support intracellular synthesis - such as citrulline, citrulline malate, the main mechanisms of action of which are supporting the urea cycle, increasing the excretion of ammonium ions, reducing the concentration lactate in the blood. The paper presents the results of a comparative pharmacoinformatic and chemoreactomic analysis of citrulline, citrulline malate (CM), carnitine, sulbutiamine and meldonium. The profile of pharmacological effects of citrulline/CM was significantly different from the profiles of other molecules. For citrulline/CM, cholinergic, antidepressant, and lipid-modifying effects have been identified and an antiasthenic effect has been suggested when used in the treatment of Duchenne muscular dystrophy and for disorders of carbohydrate metabolism. Unlike other molecules, CM and carnitine do not contribute to the loss of vitamins and minerals. Inhibition of the CM serotonin 5HT3A receptor may improve vestibulation because blockers of 5-HT3 receptors concentrated in neurons of the vestibular apparatus, improves tests of balance and walking in an experiment in mice. A positive dose-dependent effect of citrulline and CM on the lifespan of a number of model ... |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | application/pdf |
| اللغة: | Russian |
| Relation: | https://www.med-sovet.pro/jour/article/view/8187/7214; Bradley WG, Daroff RB, Fenichel GM, Jankovic J. Neurology in Clinical Practice. 1st ed. Philadelphia, PA: Elsevier; 2004. Vol 1, 1070 p.; Layzer RB. Asthenia and the chronic fatigue syndrome. Muscle Nerve. 1998;21(12):1609–1611. https://doi.org/10.1002/(sici)1097-4598(199812)21: 1231609::aid-mus1>3.0.co;2-k.; Euteneuer F, Ziegler MG, Mills PJ, Rief W, Dimsdale JE. In vivo β-adrenergic receptor responsiveness: ethnic differences in the relationship with symptoms of depression and fatigue. Int J Behav Med. 2014;21(5):843–850. https://doi.org/10.1007/s12529-013-9359-1.; Fogarty MJ, Losbanos LL, Craig TA, Reynolds CJ, Brown AD, Kumar R, Sieck GC. Muscle-specific deletion of the vitamin D receptor in mice is associated with diaphragm muscle weakness. J Appl Physiol (1985). 2021;131(1):95–106. https://doi.org/10.1152/japplphysiol.00194.2021.; Golomb BA, Evans MA, Dimsdale JE, White HL. Effects of statins on energy and fatigue with exertion: results from a randomized controlled trial. Arch Intern Med. 2012;172(15):1180–1182. https://doi.org/10.1001/archinternmed.2012.2171.; Громова ОА, Торшин ИЮ. Микронутриенты и репродуктивное здоровье. 2-е изд. М.: ГЭОТАР-Медиа; 2022. 832 c.; Громова ОА, Захарова ИН, Торшин ИЮ, Гришина ТР, Лиманова ОА. О патофизиологической терапии астении у детей препаратами цитруллина малата. Медицинский совет. 2017;(19):142–148. https://doi.org/10.21518/2079-701X-2017-19-142-148.; Jensen A, Glenn J, Stone M, Gray M. Effect Of Acute Citrulline-malate Supplementation On Muscular Power. Med Sci Sports Exerc. 2016;48(5S):252. https://doi.org/10.1249/01.mss.0000485759.38927.5f.; Glenn JM, Gray M, Jensen A, Stone MS, Vincenzo JL. Acute Citrulline-Malate Supplementation Increases Strength and Endurance During Isokinetic Exercise in Masters-Aged Female Tennis Players. Med Sci Sports Exerc. 2016;48(5S):251. https://doi.org/10.1249/01.mss.0000485757.31118.50.; Glenn JM, Gray M, Jensen A, Stone MS, Vincenzo JL. Acute citrulline-malate supplementation improves maximal strength and anaerobic power in female, masters athletes tennis players. Eur J Sport Sci. 2016;16(8):1095–1103. https://doi.org/10.1080/17461391.2016.1158321.; Cunniffe B, Papageorgiou M, OʼBrien B, Davies NA, Grimble GK, Cardinale M. Acute Citrulline-Malate Supplementation and High-Intensity Cycling Performance. J Strength Cond Res. 2016;30(9):2638–2647. https://doi.org/10.1519/JSC.0000000000001338.; Торшин ИЮ, Громова ОА, Федотова ЛЭ, Громов АН, Рудаков КВ. Хемореактомный анализ молекул цитруллина и малата. Неврология, нейропсихиатрия, психосоматика. 2017;9(1):30–35. https://doi.org/10.14412/2074-2711-2017-2-30-35.; Torshin IYu. Physiology and Medicine: Bioinformatics in the Post-Genomic Era. New York: Nova Biomedical Books; 2007. 302 p.; Рудаков КВ, Торшин И.Ю. Об отборе информативных значений признаков на базе критериев разрешимости в задаче распознавания вторичной структуры белка. Доклады Академии наук. 2011;441(1):24–28.; Torshin IY. On solvability, regularity, and locality of the problem of genome annotation. Pattern Recognit Image Anal. 2010;20:386–395. https://doi.org/10.1134/S1054661810030156.; Торшин ИЮ, Громова ОА, Сардарян ИС, Федотова ЛЭ. Cравнительный хемореактомный анализ мексидола. Журнал неврологии и психиатрии им. С.С. Корсакова. 2017;117(1–2):75–83.https://doi.org/10.17116/jnevro20171171275-84.; Bolton EE, Wang Y, Thiessen PA, Bryant SH. Chapter 12 – PubChem: Integrated Platform of Small Molecules and Biological Activities. In: Wheeler RA, Spellmeyer DC (eds.). Annual Reports in Computational Chemistry. American Chemical Society, Washington, DC: Elsevier; 2008. Vol 4. https://doi.org/10.1016/S1574-1400(08)00012-1.; Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N et al. HMDB: the Human Metabolome Database. Nucleic Acids Res. 2007;35:521–526. https://doi.org/10.1093/nar/gkl923.; Paquette AG, Marsit CJ. The developmental basis of epigenetic regulation of HTR2A and psychiatric outcomes. J Cell Biochem. 2014;115(12):2065–2072. https://doi.org/10.1002/jcb.24883.; Piche T, Vanbiervliet G, Cherikh F, Antoun Z, Huet PM, Gelsi E et al. Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study. Gut. 2005;54(8):1169–1173. https://doi.org/10.1136/gut.2004.055251.; Takimoto Y, Ishida Y, Nakamura Y, Kamakura T, Yamada T, Kondo M et al. 5-HT(3) receptor expression in the mouse vestibular ganglion. Brain Res. 2014;1557:74–82. https://doi.org/10.1016/j.brainres.2014.02.016.; Harnett MT, Chen W, Smith SM. Calcium-sensing receptor: a high-affinity presynaptic target for aminoglycoside-induced weakness. Neuropharmacology. 2009;57(5–6):502–505. https://doi.org/10.1016/j.neuropharm.2009.07.031.; Morimoto Y, Zhang Q, Adachi K. Effects of memantine, an N-methyl-D-aspartate receptor antagonist, on fatigue and neuronal brain damage in a rat model of combined (physical and mental) fatigue. Biol Pharm Bull. 2012;35(4):481–486. https://doi.org/10.1248/bpb.35.481.; Dagnino APA, da Silva RBM, Chagastelles PC, Pereira TCB, Venturin GT, Greggio S et al. Nociceptin/orphanin FQ receptor modulates painful and fatigue symptoms in a mouse model of fibromyalgia. Pain. 2019;160(6):1383–1401. https://doi.org/10.1097/j.pain.0000000000001513.; Yamada N, Katsuura G, Tatsuno I, Kawahara S, Ebihara K, Saito Y, Nakao K. Orexins increase mRNA expressions of neurotrophin-3 in rat primary cortical neuron cultures. Neurosci Lett. 2009;450(2):132–135. https://doi.org/10.1016/j.neulet.2008.11.028.; Chepke C, Jain R, Rosenberg R, Moline M, Yardley J, Pinner K et al. Improvement in fatigue and sleep measures with the dual orexin receptor antagonist lemborexant in adults with insomnia disorder. Postgrad Med. 2022;134(3):316–325. https://doi.org/10.1080/00325481.2022.2049553.; Pollak KA, Swenson JD, Vanhaitsma TA, Hughen RW, Jo D, White AT et al. Exogenously applied muscle metabolites synergistically evoke sensations of muscle fatigue and pain in human subjects. Exp Physiol. 2014;99(2):368–380. https://doi.org/10.1113/expphysiol.2013.075812.; Cannon JG, Angel JB, Abad LW, Vannier E, Mileno MD, Fagioli L et al. Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome. J Clin Immunol. 1997;17(3):253–261. https://doi.org/10.1023/a:1027314713231.; Adam Z, Szturz P, Bučková P, Cervinková I, Koukalová R, Rehák Z et al. Interleukin-1 receptor blockade with anakinra provided cessation of fatigue, reduction in inflammation markers and regression of retroperitoneal fibrosis in a patient with Erdheim-Chester disease – case study and a review of literature. Vnitr Lek. 2012;58(4):313–318. Available at: https://pubmed.ncbi.nlm.nih.gov/22559807.; Mojumdar K, Liang F, Giordano C, Lemaire C, Danialou G, Okazaki T et al. Inflammatory monocytes promote progression of Duchenne muscular dystrophy and can be therapeutically targeted via CCR2. EMBO Mol Med. 2014;6(11):1476–1492. https://doi.org/10.15252/emmm.201403967.; Gambuzza ME, Salmeri FM, Soraci L, Soraci G, Sofo V, Marino S, Bramanti P. The Role of Toll-Like Receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A New Promising Therapeutic Approach?. CNS Neurol Disord Drug Targets. 2015;14(7):903–914. https://doi.org/10.2174/1871527314666150325235247.; Vichaya EG, Ford BG, Quave CB, Rishi MR, Grossberg AJ, Dantzer R. Toll-like receptor 4 mediates the development of fatigue in the murine Lewis Lung Carcinoma model independently of activation of macrophages and microglia. Psychoneuroendocrinology. 2020;122:104874. https://doi.org/10.1016/j.psyneuen.2020.104874.; https://www.med-sovet.pro/jour/article/view/8187 |
| DOI: | 10.21518/ms2024-116 |
| الاتاحة: | https://www.med-sovet.pro/jour/article/view/8187 https://doi.org/10.21518/ms2024-116 |
| Rights: | Authors publishing their articles in this journal shall agree to the following:Authors reserve the copyright to the work and grant the journal a license to publish the work for the first time Creative Commons Attribution License (CC BY- NC-ND), which allows other persons to distribute this work with the obligatory preservation of references to the authors of the original work and the original publication in this journal.Authors reserve the right to conclude separate contractual arrangements regarding the non-exclusive distribution of the work version in the form published here (for example, posting it in the institute’s repository, publication in a book), with reference to its original publication in this journal.Authors have the right to post work on the Internet (for example, in the institute’s repository or personal website) before and during the process of considering it by this journal, as this can result in a productive discussion and more references to this work. ; Авторы, публикующие в данном журнале, соглашаются со следующим:Авторы сохраняют за собой авторские права на работу и предоставляют журналу право первой публикации работы на условиях лицензии Creative Commons Attribution License (CC BY- NC-ND), которая позволяет другим распространять данную работу с обязательным сохранением ссылок на авторов оригинальной работы и оригинальную публикацию в журнале.Авторы сохраняют право заключать отдельные контрактные договорённости, касающиеся не-эксклюзивного распространения версии работы в опубликованном виде (например, размещение ее в институтском хранилище, публикацию в книге), со ссылкой на ее оригинальную публикацию.Авторы имеют право размещать работу в сети Интернет (например в институтском хранилище или персональном сайте) до и во время процесса рассмотрения ее данным журналом, так как это может привести к продуктивному обсуждению и большему количеству ссылок на данную работу. (См. The Effect of Open Access). |
| رقم الانضمام: | edsbas.2379E9DC |
| قاعدة البيانات: | BASE |
| DOI: | 10.21518/ms2024-116 |
|---|